Cited by

• ApoA-I/A-II-HDL positively associates with apoB-lipoproteins as a potential atherogenic indicator.

  Kido T, Kondo K, Kurata H, Fujiwara Y, Urata T, Itakura H, Yokoyama S. Kido T, et al. Lipids Health Dis. 2017 Nov 29;16(1):225. doi: 10.1186/s12944-017-0619-y. Lipids Health Dis. 2017. PMID: 29187200 Free PMC article.
• Apolipoprotein A-II and Serum High-Density Lipoproteins: A Model System for the Study of Protein-Lipid Interactions at a Natural Hydrophilic-Hydrophobic Interface.

  Scanu AM, Lagocki P, Edelstein C, Byrne R. Scanu AM, et al. Biophys J. 1982 Jan;37(1):179-81. doi: 10.1016/S0006-3495(82)84660-2. Biophys J. 1982. PMID: 19431467 Free PMC article. No abstract available.
• The role of apoproteins AI and AII in binding of high-density lipoprotein3 to membranes derived from bovine aortic endothelial cells.

  Vadiveloo PK, Fidge NH. Vadiveloo PK, et al. Biochem J. 1992 May 15;284 ( Pt 1)(Pt 1):145-51. doi: 10.1042/bj2840145. Biochem J. 1992. PMID: 1599393 Free PMC article.
• Comparison of the structural and functional effects of monomeric and dimeric human apolipoprotein A-II in high density lipoprotein particles.

  Lund-Katz S, Murley YM, Yon E, Gillotte KL, Davidson WS. Lund-Katz S, et al. Lipids. 1996 Nov;31(11):1107-13. doi: 10.1007/BF02524284. Lipids. 1996. PMID: 8934442
• High density lipoprotein exchange reactions.

  Loeb J, Dawson G. Loeb J, et al. Mol Cell Biochem. 1983;52(2):161-76. doi: 10.1007/BF00224925. Mol Cell Biochem. 1983. PMID: 6410179 Review.